CD is a common disease that profoundly affects quality of life. Although immunosuppressive drugs are standard treatments, their long-term use is associated with adverse effects. Given these limitations and the global trend toward complementary and traditional therapies, further investigation in this field appears warranted (
18). This trial evaluated, for the first time, the efficacy of CLA, a turmeric-based formulation from Persian medicine, in patients with mild-to-moderate CD. Application of CLA for 4 weeks resulted in a significant improvement in TEWL. A water gradient exists across the epidermis, causing passive diffusion of water from the inner layers toward the stratum corneum. This water loss from the skin, caused by evaporation in the absence of sweating, is termed TEWL (
19). Disruption of the skin barrier and immune dysregulation can increase TEWL, leading to dry skin, pruritus, and impaired quality of life. Breaking this cycle is therefore important for clinical recovery. Decreased TEWL is positively associated with clinical improvement and better skin parameters (
20).
Stratum corneum hydration improved significantly within both groups; however, the between-group difference was not statistically significant (P = 0.515). The reduction in TIS scores was also notable (
Table 3).
Curcumin, a polyphenolic, curcuminoid-rich component of
C. longa, can inhibit the biosynthesis of prostaglandins and inflammatory mediators, including lipoxygenase, cyclooxygenase, tumor necrosis factor α, and interleukin 6 (
21). In addition to its anti-inflammatory effects, curcumin has been shown to upregulate the expression of proliferating cell nuclear antigen in skin tissues, thereby promoting wound healing. This effect has been attributed to the stimulation of transforming growth factor β and its role in extracellular matrix production and angiogenesis. Because of these properties,
C. longa is a candidate ingredient for moisturizers intended to repair the skin barrier (
22).
Lawsone (2-hydroxy-1,4-naphthoquinone) is the main component of
L. inermis. Although it has anti-inflammatory properties, it has also been identified as a cause of CD (
23). Accordingly, the extraction process for
L. inermis in this study was designed to minimize lawsone content while preserving antioxidant and free-radical-scavenging properties. The major constituents in the aqueous extract were ferulic acid, gallic acid, and luteolin (
24). These compounds have demonstrated anti-inflammatory activity by decreasing tumor necrosis factor α and interleukin 6 and inhibiting nuclear factor κB activation (
25). Aristolochic acid, one of the main constituents of
A. rotunda, can regulate prostaglandin synthesis, inhibit phospholipase A, and decrease eicosanoids and platelet-activating factors (
26).
The number of clinical trials and research articles on herbal treatments for CD remains small but has continued to increase. To our knowledge, no clinical trial has previously investigated this specific formulation. A related formulation is an ointment containing henna and curcumin (Alpha® Ointment). Studies have investigated Alpha ointment for wound healing and dermatitis and have reported positive results.
Three clinical trials conducted between 2001 and 2014 investigated the effects of
C. longa on eczema. These studies reported wound-healing properties of
C. longa treatments, attributed to enhanced angiogenesis and antimicrobial and anti-inflammatory effects. However, because most formulations contained combinations of herbal preparations, the evidence remains insufficient to establish the effect of
C. longa alone in topical preparations (
27). Supporting our findings, Suryawati et al. demonstrated that a
C. longa nanoemulgel improved atopic dermatitis-like lesions in mice by repairing the skin barrier (
28).
Few studies have investigated topical
L. inermis for dermatitis. Our results are consistent with those of Niazi et al. (
12), who found that topical
L. inermis improved CD in lower-limb prosthesis users. Keshavarz et al. compared an
L. inermis product with hydrocortisone for diaper dermatitis and found a better response in the
L. inermis group (
29).
No studies were found that investigated topical
A. rotunda for dermatologic conditions. However, given its anti-inflammatory properties (
30), this extract could plausibly be beneficial. The combination used in CLA cream may therefore produce a synergistic effect that contributes to the observed clinical effects.
5.1. Limitations
This study has several limitations. First, the sample size was relatively small. Second, because of the lack of a standard treatment for CD, comparison with an established reference therapy was not possible. Finally, a longer trial duration may have yielded more pronounced effects.
5.2. Conclusions
According to the study results, CLA cream was associated with reductions in TEWL and TIS scores. Stratum corneum hydration improved significantly within both groups but did not differ significantly between groups. CLA may therefore be considered a complementary remedy for improving symptoms in patients with mild-to-moderate CD.